stage

AIN
IonescuTx

IonescuTx

West ,  United States

The goal of IonescuTx is to discover disease-modifying small-molecule therapeutics for late-onset Alzheimer's Disease (LOAD). We are focused on correcting ApoE4 function to stop lipid dysregulation in the brain that leads to neurodegeneration.

Funding Type
Equity
Investor Role
Any
Minimum
£7,000
Previous
£0
raised
£0
Stage
Pre-Startup/R&D
Target
£7,400,000
Can’t find the information you’re looking for?

Highlights

  • ApoE4 is the strongest genetic risk factor for Alzheimer's disease
  • Current approaches focus on plaques and aggregates, which lack efficacy
  • Substantial evidence suggests ApoE4 causes Alzheimer's disease progression

The Business

Lorem ipsum dolor sit amet consectetur adipiscing elit. Quisque faucibus ex sapien vitae pellentesque sem placerat. In id cursus mi pretium tellus duis convallis. Tempus leo eu aenean sed diam urna tempor. Pulvinar vivamus fringilla lacus nec metus bibendum egestas. Iaculis massa nisl malesuada lacinia integer nunc posuere. Ut hendrerit semper vel class aptent taciti sociosqu. Ad litora torquent per conubia nostra inceptos himenaeos.

Lorem ipsum dolor sit amet consectetur adipiscing elit. Quisque faucibus ex sapien vitae pellentesque sem placerat. In id cursus mi pretium tellus duis convallis. Tempus leo eu aenean sed diam urna tempor. Pulvinar vivamus fringilla lacus nec metus bibendum egestas. Iaculis massa nisl malesuada lacinia integer nunc posuere. Ut hendrerit semper vel class aptent taciti sociosqu. Ad litora torquent per conubia nostra inceptos himenaeos.

The Market

Lorem ipsum dolor sit amet consectetur adipiscing elit. Quisque faucibus ex sapien vitae pellentesque sem placerat. In id cursus mi pretium tellus duis convallis. Tempus leo eu aenean sed diam urna tempor. Pulvinar vivamus fringilla lacus nec metus bibendum egestas. Iaculis massa nisl malesuada lacinia integer nunc posuere. Ut hendrerit semper vel class aptent taciti sociosqu. Ad litora torquent per conubia nostra inceptos himenaeos.

Progress

Lorem ipsum dolor sit amet consectetur adipiscing elit. Sit amet consectetur adipiscing elit quisque faucibus ex. Adipiscing elit quisque faucibus ex sapien vitae pellentesque.

The Team

Lorem ipsum dolor sit amet consectetur adipiscing elit. Amet consectetur adipiscing elit quisque faucibus ex sapien. Quisque faucibus ex sapien vitae pellentesque sem placerat. Vitae pellentesque sem placerat in id cursus mi.

Hugo A.

Hugo A.

Director

View LinkedIn Profile
Lorem ipsum dolor sit amet consectetur adipiscing elit. Dolor sit amet consectetur adipiscing elit quisque faucibus.
Hugo A.
Lorem ipsum dolor sit amet consectetur adipiscing elit. Dolor sit amet consectetur adipiscing elit quisque faucibus.

Documents

Have a question?

If the information provided doesn’t help, ask the proposal creator directly!

Tags

lock

Open an investor account to get full access to this pitch

Can’t find the information you’re looking for?
This promotion is exempt from the general restriction in section 21 of the Financial Services and Markets Act 2000 on the communication of invitations or inducements to engage in investment activity on the grounds it is made exclusively to ‘investment professionals’ within the meaning of Article 19 of the Financial Services and Markets Act (Financial Promotion) Order 2005 (FinProm); persons believed on reasonable grounds to be ‘certified high net worth individuals’ within the meaning of Article 48 FinProm; persons who are ‘certified sophisticated investors’ within the meaning of Article 50 FinProm; and persons who are ‘self-certified sophisticated investors’ within the meaning of Article 50A FinProm.

If you are in any doubt about the investment to which this email relates, you are strongly recommended to consult an appropriately authorised financial adviser qualified to give advice in relation to investment. This investment opportunity will not necessarily be suitable for all recipients of this email. Applications to subscribe for shares will only be accepted at the company's discretion from persons eligible to invest.
Loading…
Loading the web debug toolbar…
Attempt #